Funding Daily Summary
Funding Daily Summary: What Happened on October 29, 2026
UK budget includes £1 billion biopharma package
Exogenus Therapeutics will lead a five-year, €13 million European project to advance an osteoarthritis therapy.
-
P
Today in brief
A £1 billion biopharma investment package is part of the UK budget.1
Exogenus Therapeutics is set to lead a European consortium project for its osteoarthritis candidate EXO-101.2
Also worth knowing
-
The 10-organization Horizon Europe consortium has €13 million for a five-year project supporting Phase 1 and Phase 2 development of EXO-101, plus manufacturing, quality-control and regulatory work. Exogenus expects first-in-human Phase 1b studies to start in early 2028.2
-
P
The UK budget includes a £1 billion investment package for biopharma.1